If you handed an immortality researcher a magic wand and told him to design a drug that, in pulse-dose form, slows aging across more species than any other compound in history — he would not invent something new. He would just point at rapamycin and ask why we are still arguing about it. The molecule was scraped off a soil sample on Easter Island in 1972. It has been in clinical use for thirty years. It is one of the best-validated geroprotective drugs we have. And almost no primary care doctor in the country will prescribe it for that purpose.
The Easter Island Story
In 1964, a Canadian-led expedition collected soil samples from Rapa Nui — Easter Island. From those samples, researchers at Ayerst (now Wyeth) isolated a metabolite produced by the bacterium Streptomyces hygroscopicus. They named it rapamycin, after the place. Initially, it was developed as an antifungal. Then it turned out to be a potent immunosuppressant, and it was approved for transplant rejection prevention under the name Sirolimus.
The aging-relevant breakthrough came much later. In 2009, the NIA Interventions Testing Program reported that rapamycin extended median and maximum lifespan in genetically heterogeneous mice — males and females, in multiple labs, with the result replicating cleanly. This was the first time any drug had unambiguously extended lifespan in mammals. The result has held up.
Tony huge law of Biochemistry Physics #9
The ninth law: the molecules that extend lifespan most reliably are the ones that turn down growth signaling on the right schedule. mTOR is the central growth and nutrient-sensing pathway in the cell. Chronically high mTOR signal is good for growth and bad for longevity. Chronically low mTOR signal is bad for everything. The right answer is pulsatile suppression. That is exactly what rapamycin does when used correctly.
What mTOR Is
mTOR — mechanistic target of rapamycin — is the kinase that integrates signals from amino acids, insulin, IGF-1, and energy status, and tells the cell when to grow, build, and reproduce, versus when to clean up, autophagy, and repair. It is the master switch between “feast” mode and “fast” mode.
Modern Western life keeps mTOR pinned in the “feast” position basically forever. Constant feeding, constant insulin signal, constant amino acid availability. The result is constant growth signal — which favors cancer growth, aging, and senescent cell accumulation, even as it makes muscle building easier.
Rapamycin partially inhibits mTOR (specifically the mTORC1 complex) and shifts the cell toward the autophagy/repair side of the switch. The trick is doing that intermittently — strong pulses, long gaps — so you get the longevity benefit without compromising the growth functions you actually want.
How Geroscience Doctors Actually Use It
The current pulse-dose protocols circulating in geroscience clinics — the ones used by people like Alan Green, Peter Attia, and others openly discussing it — converge around:
- 5–8 mg, once per week
- Off the rest of the week
- Cycled long-term, with periodic breaks
This is not the chronic daily dosing used for transplant immunosuppression. That dosing produces meaningful side effects — mouth sores, lipid changes, infection risk. Pulse dosing once a week appears to capture the longevity-relevant inhibition of mTORC1 without producing chronic immunosuppression. The relevant safety question is no longer “is daily rapamycin safe” — we know it isn’t, in healthy people — but “is weekly pulsed rapamycin safe,” and the evidence so far suggests yes.
Bloodwork To Track
Before starting and every 3 months: fasting lipids, fasting glucose, HbA1c, complete metabolic panel, CBC. Rapamycin can elevate triglycerides and LDL in some people; watch the lipid panel. It can also produce mild hyperglycemia in a subset; watch the glucose. See the full bloodwork protocol for the rest of the longevity panel.
Stacking Logic
Rapamycin pairs well with the rest of the longevity layer of the Enhanced Athlete Protocol:
- Fisetin senolytic pulses, in different weeks
- NAD+ precursors plus NNMT inhibition (5-Amino-1MQ)
- Standard supplement stack
- The full hormone protocol
The interesting interaction is with the muscle-building layer. mTOR suppression is the opposite of what you want during a heavy bulk. The standard workaround is to time the rapamycin dose on a low-training day or rest day, and to lift heavy the day before and after the off-week. The pulse-dosing schedule was literally designed to permit normal training and growth across the rest of the week.
What Rapamycin Is Not
It is not an anabolic. It is not a stim. It does not feel like anything in the moment. It is a quiet, infrastructural longevity tool that compounds over years. If you are looking for a peptide that makes you feel stronger this week, this is the wrong shelf — look in the peptide chapter.
It is also not a substitute for the foundation. A man eating garbage, drinking, and sedentary will not extend his lifespan by adding rapamycin. The foundational interventions — training, real food, deep sleep, sensible alcohol intake (zero), social connection — do more than any drug. Rapamycin is what you add to a foundation that is already in place.
The Hypocrisy Angle
The same medical system that hesitates to prescribe rapamycin off-label for longevity in a 50-year-old man with normal labs is perfectly happy to prescribe statins, SSRIs, and PPIs to that same man across decades, often without compelling indication, often with worse safety profiles. The rapamycin hesitation is not about evidence. It is about regulatory inertia, malpractice liability, and the fact that no pharma company has a remaining patent to fund a Phase III geroscience trial. Once you see the pattern, you cannot unsee it.
Where Rapamycin Fits
Rapamycin is one of the cleanest, most-studied geroprotective molecules available. It is the closest thing geroscience has to a flagship intervention. It belongs in the longevity layer of the Enhanced Athlete Protocol, in conversation with a physician who actually understands the pulse-dosing literature. Build the foundation first with the beginner on-ramp, lock in the nutrition and training layers, and then layer rapamycin in as part of the Longevity Escape Velocity arc — full system at the protocol hub.